AzTrials
AzTrials

Term PregnancyDopplerNCT04158609

Relationship Between Delivery Route and Fetal Complications With Doppler Indices and CPR Parameters

An observational study of Term Pregnancy and Doppler Parameters, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Term pregnancies within their 37-41 gestational week, who were planned to undergo induction of labor, were included in the study. Prior to initiation of the induction of labor, all included pregnant women underwent an assessment of Doppler flow indices, which included fetal umblical artery PI (pulsatility index) and… Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
What is being tested?
Doppler flow indices assessment
How many people
145 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Dec 2018to 31 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Term pregnancies within their 37-41 gestational week, who were planned to undergo induction of labor, were included in the study. Prior to initiation of the induction of labor, all included pregnant women underwent an assessment of Doppler flow indices, which included fetal umblical artery PI (pulsatility index) and fetal middle cerebral artery (MCA:Middle cerebral arter) PI.

Who may be able to join

  • Term pregnancies between 37 and 41 gestational weeks Pregnancies destined to induction of labor

Who cannot join

  • history of uterine scar, nonverteks presentation, multiple pregnancies, use of vacuum of forceps at delivery, shoulder dystocia, confirmed fetal structural or chromosomal anomalies

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Medeniyet University

    Istanbul, 34722

Other trials in Turkey (Türkiye)

About this study

Official title: Assessment of the Relationship Between Delivery Route, Umbilical Cord pH and Fetal Complications With Doppler Parameters Measured Prior to Induction of Labor at Term Pregnancies.

Term pregnancies within their 37-41 gestational week, who were planned to undergo induction of labor, were included in the study. Prior to initiation of the induction of labor, all included pregnant women underwent an assessment of Doppler flow indices, which included fetal umblical artery PI (pulsatility index) and fetal middle cerebral artery (MCA:Middle cerebral arter) PI. Cerebroplacental Ratio (CPR) was calculated by dividing MCA PI value to umbilical artery PI (MCA PI/UA PI=CPR).Included pregnant women were categorized as Group 1 and Group 2, which comprised of those with CPR value below 1.0 and above 1.0, respectively. Route of delivery and fetal complications, described as umbilical cord pH<7.20, APGAR score at 5 minutes <7, meconium aspiration syndrome, newborn intensive care unit admission, neonatal sepsis and neonatal death.

Read the detailed description

Term pregnancies within their 37-41 gestational week, who were planned to undergo induction of labor, were included in the study. Prior to initiation of the induction of labor, all included pregnant women underwent an assessment of Doppler flow indices, which included fetal umblical artery PI (pulsatility index) and fetal middle cerebral artery (MCA:Middle cerebral arter) PI. Cerebroplacental Ratio (CPR) was calculated by dividing MCA PI value to umbilical artery PI (MCA PI/UA PI=CPR).Included pregnant women were categorized as Group 1 and Group 2, which comprised of those with CPR value below 1.0 and above 1.0, respectively. All women who were considered appropriate for induction of labor were performed an pelvic examination and their Bishop scores were calculated. Those with a Bishop score equal to or below 5 were included in the study. Vaginal misoprostol (prostoglandin E1, 25 mcg) and dinoproston (prostoglandin E2, 10 mg) were used for induction of labor. Repeat doses were implemented in case of insufficient cervical ripening. Oxytocin was not used at the initial stages of labour, while it was used at the latter stages when necessary.

Route of delivery and fetal complications, described as umbilical cord pH<7.20, APGAR score at 5 minutes <7, meconium aspiration syndrome, newborn intensive care unit admission, neonatal sepsis and neonatal death.

Being tested
Doppler flow indices assessment
Keywords
term pregnancy, Doppler parameters, Cerebroplacental ratio, Induction of labor

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Doppler flow indices assessmentDiagnostic test

    Doppler flow indices, UA-PI, MCA-PI and CPR values, assessment performed prior to induction of labor

Study groups in NCT04158609
Study groupRoleWhat they receive
Group 1Pregnant women with CPR value below 1, based on Doppler indices assessment
Receives: Diagnostic Test: Doppler flow indices assessment
Group 2Pregnant women with CPR value equal to or above 1, based on Doppler indices assessment
Receives: Diagnostic Test: Doppler flow indices assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Umblical arter pH

    Umbilical cord blood sampling just after the delivery of the newborn and pH measurement

    Measured: Within 1-3 minutes following delivery

  2. APGAR score at 5 minutes

    APGAR score determined by the pediatrician at postpartum 5 minutes

    Measured: Postpartum 5 minutes

  3. Meconium aspiration syndrome

    Meconium aspiration syndrome diagnosed by the pediatrician, either clinically or by thorax X-ray film.

    Measured: Within postpartum two weeks

  4. Newborn intensive care unit administration

    Newborn intensive care unit administration, due to a variety of conditions, which were established by pediatrician

    Measured: Within postpartum 1 month period

  5. Neonatal sepsis

    Neonatal sepsis diagnosed by the pediatrician

    Measured: Within postpartum 1 month period

  6. Neonatal death

    Neonatal death

    Measured: Within postpartum 1 month period

Secondary outcomes (1)
  1. Route of delivery

    Route of delivery, either vaginally or by cesarean section

    Measured: At the time of delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Nov 2019
  2. Study start1 Dec 2018
  3. Primary completion30 Sep 2019
  4. Study completion31 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
145 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04158609
Sponsor's protocol ID
2018/0473
Acronym
Doppler
Status last verified
Nov 2019
First submitted
7 Nov 2019
Last updated
13 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Term Pregnancy and Doppler Parameters, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Umblical arter pH (time frame: Within 1-3 minutes following delivery). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2019; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in